Amundi Asset Management US’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$116M Buy
3,170,392
+722,453
+30% +$26.6M 0.09% 240
2020
Q4
$88.9M Buy
2,447,939
+1,668,136
+214% +$56.5M 0.08% 273
2020
Q3
$23.3M Buy
779,803
+617,587
+381% +$19.3M 0.02% 504
2020
Q2
$4.82M Sell
162,216
-30,712
-16% -$910K 0.01% 882
2020
Q1
$5.12M Sell
192,928
-57,511
-23% -$2.18M 0.01% 732
2019
Q4
$10.6M Buy
250,439
+151,613
+153% +$6.42M 0.01% 734
2019
Q3
$4.13M Sell
98,826
-4,578
-4% -$178K 0.01% 915
2019
Q2
$3.8M Buy
103,404
+5,972
+6% +$218K ﹤0.01% 1020
2019
Q1
$3.72M Sell
97,432
-90,869
-48% -$3.37M 0.01% 969
2018
Q4
$6.62K Sell
188,301
-80,181
-30% -$2.78M 0.01% 768
2018
Q3
$8.8M Sell
268,482
-25,898
-9% -$824K 0.01% 771
2018
Q2
$9.13M Buy
294,380
+21,806
+8% +$623K 0.01% 758
2018
Q1
$7.37M Sell
272,574
-13,411
-5% -$358K 0.01% 765
2017
Q4
$7.88M Buy
+285,985
New +$8.26M 0.01% 731

Other funds holding OHI

Amundi Asset Management US's OHI Position: Q1 2021 in Review

Amundi Asset Management US increased its Omega Healthcare (OHI) stake by 30% in Q1 2021, buying an estimated $26.6M and bringing the position to 3,170,392 shares worth $116M. The position accounts for 0.09% of the portfolio, ranked #240.

Amundi Asset Management US first reported a position in OHI in Q4 2017 and has held it in 14 quarters since. 523 funds tracked by Wall St. Rank hold OHI as of Q1 2021.

  • Amundi Asset Management US held 3,170,392 shares of Omega Healthcare worth $116M as of Q1 2021.
  • Amundi Asset Management US bought 722,453 Omega Healthcare shares in Q1 2021, an estimated $26.6M.
  • Omega Healthcare made up 0.09% of Amundi Asset Management US's portfolio in Q1 2021, its #240 holding.
  • Amundi Asset Management US first reported a position in Omega Healthcare in Q4 2017 and has held it in 14 quarters since.
  • 523 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.